Sedana Medical (Sweden) Performance
| SEDANA Stock | SEK 10.16 0.30 2.87% |
The entity has a beta of 1.45, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sedana Medical will likely underperform. At this point, Sedana Medical AB has a negative expected return of -0.96%. Please make sure to validate Sedana Medical's skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Sedana Medical AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Sedana Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 376.2 M | |
| Total Cashflows From Investing Activities | -110.3 M |
Sedana |
Sedana Medical Relative Risk vs. Return Landscape
If you would invest 2,000 in Sedana Medical AB on December 24, 2024 and sell it today you would lose (984.00) from holding Sedana Medical AB or give up 49.2% of portfolio value over 90 days. Sedana Medical AB is generating negative expected returns and assumes 5.5923% volatility on return distribution over the 90 days horizon. Simply put, 49% of stocks are less volatile than Sedana, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sedana Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sedana Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sedana Medical AB, and traders can use it to determine the average amount a Sedana Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1714
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SEDANA |
Estimated Market Risk
| 5.59 actual daily | 49 51% of assets are more volatile |
Expected Return
| -0.96 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sedana Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sedana Medical by adding Sedana Medical to a well-diversified portfolio.
Sedana Medical Fundamentals Growth
Sedana Stock prices reflect investors' perceptions of the future prospects and financial health of Sedana Medical, and Sedana Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sedana Stock performance.
| Return On Equity | -0.0689 | |||
| Return On Asset | -0.0736 | |||
| Profit Margin | (0.41) % | |||
| Operating Margin | (0.74) % | |||
| Current Valuation | 1.4 B | |||
| Shares Outstanding | 99.34 M | |||
| Price To Book | 1.94 X | |||
| Price To Sales | 16.06 X | |||
| Revenue | 159.15 M | |||
| EBITDA | (43.8 M) | |||
| Cash And Equivalents | 836.18 M | |||
| Cash Per Share | 3.73 X | |||
| Total Debt | 4.64 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 10.73 X | |||
| Cash Flow From Operations | (41.22 M) | |||
| Earnings Per Share | (0.72) X | |||
| Total Asset | 1.17 B | |||
About Sedana Medical Performance
By analyzing Sedana Medical's fundamental ratios, stakeholders can gain valuable insights into Sedana Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sedana Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sedana Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sedana Medical AB , a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. Sedana Medical AB was founded in 2005 and is headquartered in Danderyd, Sweden. Sedana Medical operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 72 people.Things to note about Sedana Medical AB performance evaluation
Checking the ongoing alerts about Sedana Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sedana Medical AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sedana Medical AB generated a negative expected return over the last 90 days | |
| Sedana Medical AB has high historical volatility and very poor performance | |
| Sedana Medical AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 159.15 M. Net Loss for the year was (57.97 M) with profit before overhead, payroll, taxes, and interest of 106.71 M. | |
| Sedana Medical AB has accumulated about 836.18 M in cash with (41.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.73. | |
| Roughly 35.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Sedana Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sedana Medical's stock is overvalued or undervalued compared to its peers.
- Examining Sedana Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sedana Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sedana Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sedana Medical's stock. These opinions can provide insight into Sedana Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sedana Stock analysis
When running Sedana Medical's price analysis, check to measure Sedana Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sedana Medical is operating at the current time. Most of Sedana Medical's value examination focuses on studying past and present price action to predict the probability of Sedana Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sedana Medical's price. Additionally, you may evaluate how the addition of Sedana Medical to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |